Atıf İçin Kopyala
durmaz E., ÖZMERT E. N., ERKEKOGLU P., Giray B., Derman O., Hincal F., ...Daha Fazla
PEDIATRICS, cilt.125, sa.1, 2010 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
125
Sayı:
1
-
Basım Tarihi:
2010
-
Doi Numarası:
10.1542/peds.2009-0724
-
Dergi Adı:
PEDIATRICS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Anahtar Kelimeler:
phthalate, di-(2-ethylhexyl)-phthalate, mono-(2-ethylhexyl)-phthalate, endocrine disrupter, puberty, gynecomastia, N-BUTYL PHTHALATE, SEXUAL-DIFFERENTIATION, TESTOSTERONE SYNTHESIS, GENE-EXPRESSION, MALE-RAT, EXPOSURE, DI-(2-ETHYLHEXYL)-PHTHALATE, TAMOXIFEN, DEHP, DI(2-ETHYLHEXYL)PHTHALATE
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
OBJECTIVE: Several untoward health effects of phthalates, which are a group of industrial chemicals with many commercial uses including personal-care products and plastic materials, have been defined. The most commonly used, di-(2-ethylhexyl)-phthalate (DEHP), is known to have antiandrogenic or estrogenic effects or both. Mono-(2-ethylhexyl)-phthalate (MEHP) is the main metabolite of DEHP. In this study, we aimed to determine the plasma DEHP and MEHP levels in pubertal gynecomastia cases.